United Therapeutics | UTHR - Gross Profit On Sales



United Therapeutics reported $711M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Amarin USD 25.13M 1.78M Mar/2025
Ardelyx USD 82.84M 15.02M Jun/2025
Baxter International USD 1.14B 283M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Biogen USD 2.04B 238.8M Jun/2025
BioMarin Pharmaceutical USD 670.47M 76.89M Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
GlaxoSmithKline GBP 5.82B 229M Jun/2025
Halozyme Therapeutics USD 279.36M 62.9M Jun/2025
Insmed USD 78.08M 6.53M Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
J&J USD 14.6B 816M Mar/2025
Moderna USD 18M 1000K Jun/2025
Pfizer USD 10.88B 248M Jun/2025
PTC Therapeutics USD 163.39M 999.84M Jun/2025
Regeneron Pharmaceuticals USD 3.15B 581M Jun/2025
Sarepta Therapeutics USD 457.87M 149.43M Jun/2025
Teva Pharmaceutical Industries USD 2.1B 188M Jun/2025
United Therapeutics USD 711M 9.1M Jun/2025
Vertex Pharmaceuticals USD 2.56B 150M Jun/2025